Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
TPEN
Cat. No.:
OB0225LY-0469
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
TPEN is a metal chelator that effectively removes zinc ions from cells.
Synonym:
TPEDA; 16858-02-9; N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine; N1,N1,N2,N2-Tetrakis(pyridin-2-ylmethyl)ethane-1,2-diamine; 1,2-Ethanediamine, N,N,N',N'-tetrakis(2-pyridinylmethyl)-
CAS No.:
16858-02-9
Compound CID:
5519
Formula:
C26H28N6
Formula Weight:
424.54
Specification
Relative Density:
1.3893 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
TPEN can be used to study the role of zinc in cell biology or play an important role in neuroscience research.
Library Information
Targets:
Metal ion chelators
Receptors:
Zn2+; Mg2+; Ca2+
Pathways:
Metabolism; Apoptosis; Autophagy; Immunology/Inflammation; NF-κB
Plate Number:
AOCL-7
Plate Location:
a7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
6 mg/mL; 14.13 mM
